Company patents
Paragonix Technologies, Inc.
Paragonix Technologies, Inc. surprisingly exhibits a dominant patent focus in Biocides & Pesticides, representing 93.5% of its portfolio, despite its known medical device operations; this category saw significant growth of +225.0% in 2024 and +138.5% in 2025, though it shows a sharp decline of -67.7% so far in 2026, mirroring similar declines in Bioreactors / Cell Culture Apparatus (-71.4% so far in 2026) and Physical Therapy Apparatus (-75.0% so far in 2026), suggesting a broad shift in patenting priorities across its portfolio this year.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
62 US filings (since 2023) · 4 categories · 1 themes
Patents
Showing 1-10 of 73